| Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis. | bladder, |
| Clinical therapy and HER-2 oncogene amplification in breast cancer: chemo- vs radiotherapy. | breast, |
| [Molecular biology and immunohistochemical studies of Her2/neu oncogene in stomach cancer]. | gastric, |
| p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair. | breast, |
| [Overexpression of c-erbB-2 proto-oncogene product in chondrosarcomas]. | sarcoma, |
| Demonstration of c-erbB-2 oncogene overexpression in salivary gland neoplasms by in situ hybridization. | neoplasm, |
| Assay of the c-erbB-2 oncogene encoded protein by ELISA and immunocytochemistry in human breast cancer. | breast, |
| Immunohistochemical studies on c-erbB-2 oncoprotein expression in paraffin embedded tissues in invasive and non-invasive human breast lesions. | breast, |
| Prognostic association of c-erbB-2 oncogene amplification and protein overexpression in human breast cancer using archival tissues. A comparative study. | breast, |
| Correlations of chronic hepatitis B virus infection and cigarette smoking with elevated expression of neu oncoprotein in the development of hepatocellular carcinoma. | liver, |
| Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix. | uterine, |
| Quantitative analysis of the neu oncogene in normal and transformed epithelial breast cells by fluorescence in situ hybridization and laser scanning microscopy. | breast, |
| c-erbB-2 oncoprotein is not an independent prognostic parameter in primary breast carcinoma. An immunohistochemical study. | breast, |
| erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification. | breast, |
| Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team. | breast, |
| Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro. | pituitary, |
| Colocalization of the p185HER2 oncoprotein and integrin alpha 6 beta 4 in Calu-3 lung carcinoma cells. | lung, |
| The simultaneous expression of c-erbB-2 oncoprotein and laminin receptor on primary breast tumors has a predicting potential analogous to that of the lymph node status. | breast, |
| Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer. | gastric, |
| Human-specific c-neu proto-oncogene protein overexpression in human malignant astrocytomas before and after xenografting. | astrocytomas, |